Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies

Authors

Sean J. Miller, Pluripotent Diagnostics Corporation (PDx), Molecular Medicine Research Institute, Sunnyvale, CA, United States.
Selina Wray, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Rita Sattler, Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, United States.Follow
Can Zhang, Genetics and Aging Research Unit, Department of Neurology, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States.

Document Type

Editorial

Keywords

Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, neurodegeneration, neuropathology, proteinopathies

Publication Date

1-1-2022

Publication Title

Frontiers in neuroscience

ISSN

1662-4548

Volume

16

First Page

968994

PubMed ID

35844231

Digital Object Identifier (DOI)

10.3389/fnins.2022.968994

Recommended Citation

Miller, Sean J.; Wray, Selina; Sattler, Rita; and Zhang, Can, "Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies" (2022). Translational Neuroscience. 2253.
https://scholar.barrowneuro.org/neurobiology/2253